Researchers used an antibody attached to iodine 131 to target leukemic blood cells for radiation delivery among patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndrome, a pre-leukemic condition. The technique allowed for more radiation to reach and eliminate cancer cells in preparation for stem cell transplantation. All of the patients in the study experienced a remission in their cancers after undergoing the combined procedure.

Full Story:

Related Summaries